Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Gevo (GEVO) has a market cap of $0.27 billion USD. According to our data, Gevo is ranked No.6640 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.27 B |
-46.37%
|
| Dec 31, 2024 | $0.50 B |
80.17%
|
| Dec 29, 2023 | $0.28 B |
-38.95%
|
| Dec 30, 2022 | $0.45 B |
-55.61%
|
| Dec 31, 2021 | $1.02 B |
0.71%
|
| Dec 31, 2020 | $1.02 B |
83.98%
|
| Dec 31, 2019 | $0.55 B |
17.86%
|
| Dec 31, 2018 | $0.47 B |
-83.39%
|
| Dec 29, 2017 | $2.83 B |
-82.65%
|
| Dec 30, 2016 | $16.28 B |
-72.58%
|
| Dec 31, 2015 | $59.37 B |
-87.08%
|
| Dec 31, 2014 | $459.66 B |
-77.62%
|
| Dec 31, 2013 | $2.054 T |
-7.14%
|
| Dec 31, 2012 | $2.212 T |
-75.52%
|
| Dec 30, 2011 | $9.035 T |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Green Plains
GPRE
|
$0.23 B |
-0.000 M
|
USA
|
 Aemetis
AMTX
|
$76.25 M |
0.000 M
|
USA
|
 Codexis
CDXS
|
$0.19 B |
0.000 M
|
USA
|
 Cerevel Therapeutics
CERE
|
$8.19 B |
0.000 M
|
USA
|
 Gevo
GEVO
|
$0.27 B |
-0.000 M
|
USA
|
 Origin Materials
ORGN
|
$92.66 M |
0.000 M
|
USA
|
 Fulcrum Therapeutics
FULC
|
$0.16 B |
0.000 M
|
USA
|
| Market Cap | = | GEVO Stock Price | * | GEVO Shares Outstanding |
| = | $1.12 | * | 0.24 B | |
| = | $0.27 B |